The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between...
Results from the phase2 trial support the view that subcutaneous administration of IFN- β for treatment of COVID-19 enhances speed of recovery and reduces mortality....
Scientists have designed a new chest-laminated, ultrathin, 100 percent stretchable cardiac sensing electronic device (e-tattoo) to monitor heart functions. The device can measure ECG,...
Scientific research has proven that dogs are compassionate beings who overcome obstacles to help their human owners.
Humans have domesticated dogs for thousands of years...
A combination of biological and computational approach to study protein-protein interactions (PPIs) between the viral and the host proteins in order to identify and...
Concizumab (commercial name, Alhemo), a monoclonal antibody was approved by the FDA on 20 December 2024 for prevention of bleeding episodes in patients with...
Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has received FDA approval. It is a small interfering RNA (siRNA) based therapeutic that interfere with natural anticoagulants such as...
A novel study based on nanotechnology generates hope for treating acute kidney injury and failure.
Kidney is an essential vital organ which performs critical functions...
The solar observatory spacecraft, Aditya-L1 was successfully inserted in Halo-Orbit about 1.5 million km away from earth on 6th January 2024. It was launched on...
The APXC instrument aboard the lunar rover of ISRO’s Chandrayaan-3 moon mission conducted in-situ spectroscopic study to ascertain abundance of elements...
Scientists have developed the first patient-derived stem cell model of albinism. The model will help studying eye conditions related to oculocutaneous albinism (OCA).
Stem cells...